<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01121978</url>
  </required_header>
  <id_info>
    <org_study_id>SRIG #2</org_study_id>
    <nct_id>NCT01121978</nct_id>
  </id_info>
  <brief_title>Early Vitrectomy for Macular Tractional Maculopathy</brief_title>
  <official_title>Early Vitrectomy for Macular Tractional Maculopathy. Multicenter Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul Retina Investigator Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul Retina Investigator Group</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to identify the effect of current vitreous surgery for symptomatic
      macular tractional maculopathy.

      Characteristics of this study is as below

        1. Multicenter, prospective clinical trial. (early surgical intervention vs.surgical
           intervention when full-thickness macular hole formation or deterioration of visual
           acuity occurs)

        2. Non-randomized study (decision was made by patients after full explanation)

        3. After 1 year follow up, functional change(visual acuity)and anatomical change would be
           evaluated
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Degenerative myopia is relatively common disorder, especially in Korean, Japanese and
      Chinese.

      Choroidal neovascularization is well-noted cause of VA deterioration, but nowadays, with
      improvement of diagnostic tools, such as OCT, VA deterioration from myopic tractional
      maculopathy is being concerned as well.

      But till now, the necessity of early vitrectomy on MTM is controversial. By now some
      clinicians prefer conservative treatment, which means pars plana vitrectomy would be
      postponed till structural change such as macular hole formation is noticed. And the others
      prefer early vitrectomy, which means pars plana vitrectomy should be performed when the
      symptom begins.

      In this study, investigators try to verify the validity of early vitrectomy comparing
      conservative treatment.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2009</start_date>
  <completion_date type="Anticipated">November 2012</completion_date>
  <primary_completion_date type="Anticipated">November 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Best Corrected Visual acuity</measure>
    <time_frame>48 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of occurrence of full-thickness macular hole</measure>
    <time_frame>48 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Myopia, Degenerative</condition>
  <arm_group>
    <arm_group_label>Conservative treatment group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Eyes which do not undergo early vitrectomy at the time of enrollment. Surgical intervention would be performed when full-thickness macular hole or vision deterioration occurs</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Early vitrectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Triamcinolone acetonide assisted pars plana vitrectomy with Indocyanine green dye assisted internal limiting membrane peeling</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Early vitrectomy</intervention_name>
    <description>Triamcinolone acetonide assisted pars plana vitrectomy with Indocyanine green dye assisted internal limiting membrane peeling</description>
    <arm_group_label>Early vitrectomy</arm_group_label>
    <other_name>pars plana vitrectomy for macular tractional maculopathy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male or female with impending macular hole(identified with OCT)

          -  Age: over 20 years

          -  Symptom duration &lt; 6 Months

          -  Visual acuity on trial: more than 20/320 in ETDRS chart

        Exclusion Criteria:

          -  Any vision disturbing disease other than impending macular hole

          -  Diabetic maculopathy or other retinal vascular disease

          -  Prior history of major trauma: If symptom begins after trauma

          -  Any evidence of atrophic change, scar or exudation on macula active intraocular
             inflammation

          -  History of intraocular surgery other than uncomplicated cataract extraction 3 months
             before

          -  Uncontrolled IOP &gt; 25mmHg
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Se Woong Kang, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul Retina Investigator Group</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Se Woong Kang, M.D.</last_name>
    <phone>82-2-3410-6776</phone>
    <email>swkang@skku.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Se Woong Kang</last_name>
    <phone>82234103562</phone>
    <email>swkang@skku.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Asan Medical Center, University of Ulsan College of Medicine</name>
      <address>
        <city>Seoul</city>
        <state>82-2-3010-3673</state>
        <zip>138-736</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Young Hee Yoon, M.D.</last_name>
      <phone>82-2-3010-3673</phone>
    </contact>
    <investigator>
      <last_name>Young Hee Yoon, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <state>Gyunggi-do</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kyu Hyung Park, M.D</last_name>
      <phone>82-31-787-7373</phone>
      <email>jiani4@snu.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Kyu Hyung Park, M.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Konyang University, Myung Gok Eye Research Institute</name>
      <address>
        <city>Daejeon</city>
        <zip>302-718</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jong Woo Kim, M.D.</last_name>
      <phone>82-42-600-8816</phone>
    </contact>
    <investigator>
      <last_name>Jong Woo Kim, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HanGil Eye Hospital</name>
      <address>
        <city>In Cheon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joonhong Sohn, M.D.</last_name>
      <phone>0325033322</phone>
    </contact>
    <investigator>
      <last_name>Joonhong Sohn, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hum Chung, M.D.</last_name>
      <phone>82-2-2072-2437</phone>
    </contact>
    <investigator>
      <last_name>Hum Chung, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kangdong Sacred Heart Hospital, Hallym University College of Medicine,</name>
      <address>
        <city>Seoul</city>
        <zip>134-701</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sung Pyo Park, M.D.</last_name>
      <phone>82-2-2224-2274</phone>
    </contact>
    <investigator>
      <last_name>Sung Pyo Park, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>135-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Se Woong Kang, M.D.</last_name>
      <phone>82-2-3410-3562</phone>
      <email>swkang@skku.edu</email>
    </contact>
    <investigator>
      <last_name>Se Woong Kang, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Catholic University of Korea</name>
      <address>
        <city>Seoul</city>
        <zip>137-701</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Won-Ki Lee, M.D.</last_name>
      <phone>82-2-2258-2846</phone>
    </contact>
    <investigator>
      <last_name>Won-Ki Lee, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gangnam Sacred Heart Hospital,Hallym University</name>
      <address>
        <city>Seoul</city>
        <zip>150-950</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ha Kyoung Kim, M.D.</last_name>
      <phone>82-2-829-5193</phone>
    </contact>
    <investigator>
      <last_name>Ha Kyoung Kim, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kong eye clinic</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eun Goo Lee, M.D.</last_name>
      <phone>02-480-5000</phone>
    </contact>
    <investigator>
      <last_name>Eun Goo Lee, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 30, 2010</study_first_submitted>
  <study_first_submitted_qc>May 10, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 12, 2010</study_first_posted>
  <last_update_submitted>March 28, 2011</last_update_submitted>
  <last_update_submitted_qc>March 28, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 29, 2011</last_update_posted>
  <responsible_party>
    <name_title>Se Woong Kang</name_title>
    <organization>Samsung Medical Center</organization>
  </responsible_party>
  <keyword>macular tractional maculopathy</keyword>
  <keyword>pathologic myopia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
    <mesh_term>Myopia, Degenerative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Triamcinolone Acetonide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

